Evidence map›Paper›PMID 33505995›Full record

ArticleFrontiers in cardiovascular medicine2020

The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study).

Dike Ojji, Boni Maxime Ale, Lamkur Shedul, Ejiroghene Umuerri, Emmanuel Ejim, Chizindu Alikor, Charles Agunyenwa, Uche Njideofor, Helen Eze, Victor Ansa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dike OjjiDepartment of Internal Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Boni Maxime AleHolo Healthcare Limited, Nairobi, Kenya.
Lamkur ShedulDepartment of Family Medicine, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Ejiroghene UmuerriDepartment of Internal Medicine, Faculty of Clinical Medicine, College of Health Sciences, Delta State University, Abraka, Nigeria.
Emmanuel EjimDepartment of Internal Medicine, University of Nigeria and University of Nigeria Teaching Hospital, Enugu, Nigeria.
Chizindu AlikorDepartment of Internal Medicine, University of Port Harcourt and University of Port Harcourt Teaching, Port Harcourt, Nigeria.
Charles AgunyenwaDepartment of Internal Medicine, University of Nigeria and University of Nigeria Teaching Hospital, Enugu, Nigeria.
Uche NjideoforDepartment of Internal Medicine, University of Calabar and University of Calabar Teaching Hospital, Calabar, Nigeria.
Helen EzeCardiovacular Research Unit, Department of Internal Medicine, University of Abuja and University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Victor AnsaDepartment of Internal Medicine, University of Calabar and University of Calabar Teaching Hospital, Calabar, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

black patientsefficacyhypertensivenebivololtolerability

Identifiers

PMID33505995
PMCPMC7829216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.